Noncompartmental determination of the steady-state volume of distribution.
about
Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteersBenet L Z and Galeazzi R L: noncompartmental determination of the steady-state volume of distribution, J Pharm Sci 68, 1071-1074, 1979--the backstoryKinetic and pharmacological studies on estazolam in mice and manTrans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smokingTime Varying Apparent Volume of Distribution and Drug Half-Lives Following Intravenous Bolus InjectionsSimultaneous determination of cefazolin in rat blood and brain by microdialysis and microbore liquid chromatography.Measurement and pharmacokinetic analysis of unbound cephaloridine in rat blood by on-line microdialysis and microbore liquid chromatography.Effect of intramuscular methadone on pharmacokinetic data and thermal and mechanical nociceptive thresholds in the cat.Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life.Intra and interindividual variability in the kinetics of a poorly and highly metabolising solventSingle-dose pharmacokinetics of aztreonam in pediatric patientsEffect of lactation on single-dose pharmacokinetics of norfloxacin nicotinate in ewesAbsorption-dependent apparent volume of distribution at steady state (V(ss)/F) in pharmacokinetic data analysis.Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.Dedication to professor Leslie Z. Benet: 50 years of scientific excellence and still going strong!The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.Cefpiramide kinetics and plasma protein binding in cholestasis.Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate.Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinomaSpecificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.The effect of ranitidine on the disposition of lignocaine.Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisoneInfluence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid.Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.Effect of pirprofen on glibenclamide kinetics and response.Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration.Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgeryRanitidine disposition in patients with renal impairmentAlterations in prednisolone disposition as a result of time of administration, gender and dose.Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid eliminationFailure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaineLack of effect of tenoxicam on glibornuride kinetics and response.Verapamil disposition--effects of sulphinpyrazone and cimetidineThe effects of age and sex on the disposition of acetylsalicylic acid and its metabolitesPharmacokinetics and molecular detoxicationSodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteersThe effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis studyPharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections.Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection.
P2860
Q24679375-D193B28F-73FF-42E0-97B6-DB27F6C13244Q26866089-C6AE1560-B0F9-43A1-AC0A-99633D8D2588Q28282096-A8706F2D-D522-4892-B5A5-9A4D738876E2Q28346917-A086F57B-2B54-4C1B-9129-99B998F5A6BAQ28552575-5DE544F8-9697-4442-98A0-86A1406BA642Q30881724-C467F8D5-8B58-4DD5-A186-2300AC23CE00Q30984288-F8304D39-BCA5-4730-955B-3CDABCF0D557Q30996995-43F7E984-1B0D-47DB-B992-F6D54FA77B1DQ33492464-FC77D524-B868-4DA7-98EB-187D250BB6CCQ33577998-281D0B91-D861-486B-A899-9A317E6226A3Q33737281-A9152438-5F58-4130-B32C-C645B5A24AA8Q33760986-194C639C-62C7-4B2C-9172-BA3D91E14FE9Q34015139-1AD6414C-68A9-4C89-B811-8D57ACBA0C84Q34134336-6C2F7D1C-6AE6-4036-B14A-FDB4DCB54B8FQ34289184-AAF4A33A-5185-44FF-BFDD-7945FD9F2441Q34345976-48C67B16-8102-41FE-8AA9-A39A4924D63EQ34346158-0099B5BA-046A-4C6F-8FBE-4EED3FD58816Q34346559-56DD2BEF-D921-4259-B965-75595A0EB9D6Q34347516-8DBCFD92-F84D-4BD9-8467-E601E777CDF9Q34416625-8791802D-F9B0-4707-B3B0-0AD3289554E3Q34446662-4F2670BA-DF73-4DEF-8E25-3D3C8B4E0513Q34446735-1A97B304-E6D9-4936-9F31-E83E13356C76Q34447281-D0C25B16-FB1C-45A5-B046-C536136C0FF1Q34447873-15CEFF41-CC60-4035-9180-616CC9720F09Q34449845-5F4E98F5-7353-426D-8E18-6DB6528B263AQ34511626-116BC356-F1EC-4117-A542-E886BA5AE921Q34512449-08F30642-4F36-4C2B-A8F0-2889E47DCA3EQ34512568-7BE8D707-949E-4B66-969B-B0982B6E9F4DQ34514248-A42607A9-E2B5-4D14-BCAB-596B8DABC136Q34621156-7BC19896-7461-4A46-A03C-75AEE2E50AFCQ34621539-E86215BC-203B-4F4E-ABF6-A3CB2E9367F2Q34622076-BD3A76CA-3D5D-49EA-BA99-CF8D3E57541CQ34622265-8739DB97-EC33-40DF-937A-A3ADEB0F6604Q34622354-0C78DF16-A916-4B46-9352-F904D5F9D2ACQ34622717-DED40B82-C7EF-4A32-A0B2-1BBC21953F11Q34636589-948FD71D-FD81-468F-9953-73BB6D4CCCB1Q35030652-B28F6667-17A7-4EC1-A58C-F1B26B1210D7Q35044794-424FFFDC-C85C-4E3B-8A5C-7BE124B0EC0BQ35065838-E56DAA1D-95D7-4E48-A425-FF68453C3584Q35121815-F9B4247C-AB75-4647-9EEE-D508E7DB4615
P2860
Noncompartmental determination of the steady-state volume of distribution.
description
1979 nî lūn-bûn
@nan
1979 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Noncompartmental determination of the steady-state volume of distribution.
@ast
Noncompartmental determination of the steady-state volume of distribution.
@en
Noncompartmental determination of the steady-state volume of distribution.
@nl
type
label
Noncompartmental determination of the steady-state volume of distribution.
@ast
Noncompartmental determination of the steady-state volume of distribution.
@en
Noncompartmental determination of the steady-state volume of distribution.
@nl
prefLabel
Noncompartmental determination of the steady-state volume of distribution.
@ast
Noncompartmental determination of the steady-state volume of distribution.
@en
Noncompartmental determination of the steady-state volume of distribution.
@nl
P356
P1476
Noncompartmental determination of the steady-state volume of distribution.
@en
P2093
P304
P356
10.1002/JPS.2600680845
P407
P577
1979-08-01T00:00:00Z